MBMegan S. Barker

Megan S. Barker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Megan S. Barker has a total of 177 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Conceptualizing cognition and behaviour across amyotrophic lateral sclerosis and frontotemporal dementia

    by Michael Benatar, Edward D Huey, Chiadi U Onyike, Caroline McHutchison, Maria Carmela Tartaglia, Megan S Barker, Sharon Abrahams, Joke De Vocht, Emma Rhodes, Yolande A Pijnenburg, et al.

    Cognitive and behavioural dysfunction in frontotemporal dementia (FTD) evolves along a clinical continuum from a clinically silent stage of disease, through a prodromal period, often referred to as mild cognitive impairment (MCI) and/or mild behavioural impairment (MBI), and into a clinically manifest stage recognized by the syndromes of behavioural variant FTD and primary progressive aphasia (PPA). Similar cognitive and behavioural manifestations of varying severity are also encountered in individuals with amyotrophic lateral sclerosis (ALS). Notwithstanding this phenotypic overlap as well as a degree of shared genetic risk and underlying pathology, the approach to phenotypic characterization and description meaningfully differs between the ALS and FTD communities. The problem is particularly evident within the ALS community when describing impairment in the prodromal versus clinically manifest disease stages. Pertinent considerations include the nature of cognitive and behavioural assessments, the nosology used to describe symptoms identified, including those encompassed by the terms ‘behavioural’ and ‘neuropsychiatric’, the operationalized criteria that define prodromal syndromes and clinically manifest disease, and the extent to which these criteria rely on longitudinal (versus cross-sectional) data. A multi-stakeholder workshop, held in London, Ontario (12–14 May 2025), brought together neurologists, psychiatrists, neuropsychologists, neuropathologists, neuroscientists and neurogeneticists studying ALS and FTD, to promote interdisciplinary dialogue and to define a research agenda that might be jointly tackled to address these critical issues. A new nosology for classifying frontotemporal-related behavioural and neuropsychiatric dysfunction, which could be used to support empirical evidence collection, is proposed alongside a list of cognitive, language, behavioural and neuropsychiatric symptoms to be considered in the evaluation of individuals with ALS. Research priorities for each of the ALS and FTD communities, as well as initiatives that should be undertaken jointly, are highlighted. The long-term goal is to harmonize approaches to phenotypic characterization, the nosology used to describe symptoms and the criteria used to define landmark stages along the clinical continua of the motor neuron and frontotemporal axes, irrespective of clinical stage.


  • The Role of Apathy in the Association Between Depressive Symptoms and Subjective Cognitive Complaints

    by Megan S. Barker, Jillian L. Joyce, Leah Waltrip, Silvia Chapman, Yian Gu, Preeti Sunderaraman, Edward D. Huey, Stephanie A. Cosentino

    Objectives: Self‐perceived cognitive difficulties are a potential early marker of Alzheimer's disease (AD), frequently co‐occur with depressive symptoms. This has hindered consideration of these subjective cognitive difficulties as a risk factor for AD. However, accumulating evidence points to dissociations between specific depressive symptoms (i.e., apathy, affective or mood symptoms, and others), with some suggestion that apathy is particularly predictive of and more proximate to AD and may drive the relationship between depressive symptomatology and AD. This study examines whether apathy drives the association between depressive symptoms and subjective cognitive complaints (SCC). Methods: 151 cognitively normal older adults (68% female, mean age 73 ± 7 years) completed a 20‐item SCC questionnaire, the Apathy Evaluation Scale, and the Geriatric Depression Scale (GDS). Results: Depressive symptoms (per GDS) were significantly associated with SCC ( p = 0.008). However, affective symptoms (dysphoria, anxiety, hopelessness), were not statistically associated with SCC ( p = 0.100), while apathy symptoms were ( p < 0.001). In a mediation model, apathy mediated the relationship between depressive symptoms and SCC, accounting for 53% of the total effect, indicating that apathy may drive the relationship between depressive symptoms and SCC. When stratified by sex, the results remained significant for women only. Conclusions: These results underscore the relevance of apathy in pre‐clinical stages of AD, such as SCC, particularly in women. Understanding the complex associations between SCC and depressive symptoms will help refine conceptualization of SCC as a risk factor for AD.

  • Neuropsychiatric Symptoms in Patients With Pathologically Confirmed Comorbid Alzheimer Disease and Frontotemporal Lobar Degeneration

    by Daliah Ross, Molly Split, Zachary Kunicki, Rachel Keszycki, Sarah Prieto, Alyssa N. De Vito, Masood Manoochehri, Edward D. Huey, Megan S. Barker

    Little is known about the clinical presentation in patients with comorbid Alzheimer disease neuropathologic change (ADNC) and frontotemporal lobar degeneration (FTLD) neuropathology, despite frequent comorbidity of neurodegenerative diseases on autopsy. In other neurodegenerative conditions, multiple pathologies alter the presentation of neuropsychiatric symptoms, complicating clinical care. We examined whether neuropsychiatric symptoms differ in patients with comorbid ADNC/FTLD compared with patients with each pathology alone. This was a retrospective examination of data from 29 US Alzheimer's Disease Research Centers, obtained through the National Alzheimer's Coordinating Center September 2024 data freeze. Patients with intermediate-to-high ADNC and/or FTLD neuropathology on autopsy were included. Neuropsychiatric symptoms were apathy, depressed mood, visual/auditory hallucinations, delusions, disinhibition, irritability, agitation, personality change, REM sleep behavior disorder, and anxiety, identified by clinicians at patients' final visit. Logistic regression models examined the odds of the comorbid vs single pathology groups expressing each neuropsychiatric symptom, controlling for age, sex, race, ethnicity, education, and interval between first visit and death. Data from 919 patients (mean age 81 years [SD 12 years], 49% female) were analyzed. Ninety-four patients (mean age 84 years [SD 10 years], 46% female) had comorbid ADNC/FTLD pathology, 590 had ADNC only, and 235 had FTLD only. Compared with the FTLD-only group, patients in the comorbid ADNC/FTLD group were more likely to present with anxiety (odds ratio [OR] 3.11, 95% CI 1.38-6.98, p = 0.007), delusions (OR 2.59, 95% CI 1.15-5.79, p = 0.02), and irritability (OR 1.87, 95% CI 1.07-3.25, p = 0.03). Conversely, compared with the ADNC-only group, patients in the comorbid ADNC and FTLD group were more likely to present with personality change (OR 3.17, 95% CI 1.70-5.90, p < 0.001) and disinhibition (OR 2.00, 95% CI 1.14-3.53, p = 0.02). Comorbid presence of ADNC and FTLD neuropathology, compared with each pathology alone, was associated with a greater likelihood of presenting with known neuropsychiatric symptoms of the other disease, irrespective of patients' clinical syndrome. Findings highlight the potential clinical diagnostic value of antemortem behavioral symptoms in identifying patients with comorbid pathology, although conclusions are limited by the cross-sectional nature of the neuropsychiatric data.


  • Open Access

    Linguistic Features from Paragraph Recall are Markers of Cognitive Impairment

    by Seho Park, Nicole Roth, Megan Barker, Sanford Auerbach, Thomas T. Perls, Stephanie Cosentino, Rhoda Au, David J. Libon, Paola Sebastiani, Stacy L. Andersen

    Objective: Cognitive impairment is associated with language changes that may be elicited from verbal responses during neuropsychological assessments that are not captured in traditional scoring. The current study investigated the utility of a linguistic analysis of paragraph recall responses for differentiating participants with and without cognitive impairment. Methods: Digital voice recordings of Logical Memory (LM) were available from 598 participants from the Long Life Family Study with normal cognition and 112 with cognitive impairment. Linguistic polyfeature scores for immediate (PFS-IR) and delayed recall (PFS-DR) were created from a weighted sum of features associated with cognitive impairment. Logistic regression models assessed the predictive value of each PFS and demographics for classifying cognitive impairment. Repeated measures models with Generalized Estimating Equations assessed whether PFSs predict decline on a cognitive screener. Results: Both immediate and delayed PFSs were significantly associated with cognitive status (PFS-IR β = 0.05, p< .001; PFS-DR β = 0.07, p< .001). A classifier with PFS-DR and demographics closely approximated the accuracy of the traditional LM score and demographics (AUC-PR = 0.81 vs 0.84, respectively). A higher PFS-DR was also associated with greater cognitive decline over an average of 5 years of follow-up (β = -0.08, p< .001). Conclusion: Quantification of linguistic features from paragraph recall using a linguistic PFS provides sufficient information for detecting cognitive impairment and predicting incident cognitive decline. The linguistic PFS has the potential to be integrated into automated testing, recording, and scoring pipelines allowing for the implementation of sensitive neuropsychological assessments in broader clinical and research settings.

  • Open Access

    Excessive emotional reactivity in a case of behavioral variant frontotemporal dementia with amyotrophic lateral sclerosis

    by Megan S. Barker, Neil A. Shneider, Masood Manoochehri, Edward D. Huey, Elizabeth C. Lindenberger


  • Open Access

    Neuropsychiatric and behavioral symptom clusters in frontotemporal dementia

    by Corinne Sejourne, Megan S Barker, Madison R Heath, Yunglin Gazes, Rachel Fremont, Yedili Genao Perez, Luke J Hearne, Eric M Wassermann, Michael C Tierney, Masood Manoochehri, et al.

    Background: Non-Alzheimer's disease dementias, including frontotemporal dementia (FTD) can be difficult to characterize due to the predominance of distinct behavioral and neuropsychiatric symptoms. Widely used measurement tools lack structure and objectivity. Objective: The purpose of this study was to use systematic direct observation of neuropsychiatric and behavioral symptoms, via the Neurobehavioral Rating Scale (NBRS), to characterize clusters of behavioral and neuropsychiatric symptoms in FTD and examine how selected symptom clusters correlate with structural neuroimaging. Methods: We performed a factor analysis on the NBRS data from 172 patients with FTD and examined the neural correlates of the selected symptom clusters in a subsample of 67 patients. Results: Six factors accounted for 56% of total variance across NBRS item scores: Apathy/Blunting, Agitation/Disinhibition, Cognitive/Language, Planning/Insight, Anxiety/Lability, and Psychosis. Symptom clusters showed significant associations with specific regions of cortical thinning: Agitation/Disinhibition with bilateral frontal regions, and Cognition/Language with the left bank of the superior temporal sulcus and supramarginal regions. Conclusions: The selected symptom clusters associated with known regions of atrophy in FTD. The NBRS is an effective observational measure that may extend characterization and understanding of FTD.


  • Open Access

    Adynamic spoken language in corpus callosum dysgenesis

    by Megan S. Barker, Jacquelyn L. Knight, Ryan J. Dean, Linda J. Richards, Gail A. Robinson, A. Ceslis

  • Changes in Digital Speech Measures in Asymptomatic Carriers of Pathogenic Variants Associated With Frontotemporal Degeneration

    by Naomi Nevler, Sunghye Cho, Katheryn A.Q. Cousins, Sharon Ash, Christopher A. Olm, Sanjana Shellikeri, Galit Agmon, Carmen Gonzalez-Recober, Sharon X. Xie, Megan S. Barker, et al.

    Clinical trials developing therapeutics for frontotemporal degeneration (FTD) focus on pathogenic variant carriers at preclinical stages. Objective, quantitative clinical assessment tools are needed to track stability and delayed disease onset. Natural speech can serve as an accessible, cost-effective assessment tool. We aimed to identify early changes in the natural speech of FTD pathogenic variant carriers before they become symptomatic. In this cohort study, speech samples of picture descriptions were collected longitudinally from healthy participants in observational studies at the University of Pennsylvania and Columbia University between 2007 and 2020. Participants were asymptomatic but at risk for familial FTD. Status as "carrier" or "noncarrier" was based on screening for known pathogenic variants in the participant's family. Thirty previously validated digital speech measures derived from automatic speech processing pipelines were selected a priori based on previous studies in patients with FTD and compared between asymptomatic carriers and noncarriers cross-sectionally and longitudinally. A total of 105 participants, all asymptomatic, included 41 carriers: 12 men [30%], mean age 43 ± 13 years; education, 16 ± 2 years; MMSE 29 ± 1; and 64 noncarriers: 27 men [42%]; mean age, 48 ± 14 years; education, 15 ± 3 years; MMSE 29 ± 1. We identified 4 speech measures that differed between carriers and noncarriers at baseline: mean speech segment duration (mean difference -0.28 seconds, 95% CI -0.55 to -0.02, p = 0.04); word frequency (mean difference 0.07, 95% CI 0.008-0.14, p = 0.03); word ambiguity (mean difference 0.02, 95% CI 0.0008-0.05, p = 0.04); and interjection count per 100 words (mean difference 0.33, 95% CI 0.07-0.59, p = 0.01). Three speech measures deteriorated over time in carriers only: particle count per 100 words per month (β = -0.02, 95% CI -0.03 to -0.004, p = 0.009); total narrative production time in seconds per month (β = -0.24, 95% CI -0.37 to -0.12, p < 0.001); and total number of words per month (β = -0.48, 95% CI -0.78 to -0.19, p = 0.002) including in 3 carriers who later converted to symptomatic disease. Using automatic processing pipelines, we identified early changes in the natural speech of FTD pathogenic variant carriers in the presymptomatic stage. These findings highlight the potential utility of natural speech as a digital clinical outcome assessment tool in FTD, where objective and quantifiable measures for abnormal behavior and language are lacking.


  • Open Access

    Verbal and nonverbal fluency in amyotrophic lateral sclerosis

    by Megan S. Barker, Amelia Ceslis, Rosemary Argall, Pamela McCombe, Robert D. Henderson, Gail A. Robinson

    Amyotrophic lateral sclerosis (ALS) is a multi‐system disorder that commonly affects cognition and behaviour. Verbal fluency impairments are consistently reported in ALS patients, and we aimed to investigate whether this deficit extends beyond the verbal domain. We further aimed to determine whether deficits are underpinned by a primary intrinsic response generation impairment ( i.e ., a global reduction across tasks), potentially related to apathy, or an inability to maintain responding over time ( i.e ., a ‘drop off’ pattern). Twenty‐two ALS patients and 21 demographically‐matched controls completed verbal and nonverbal fluency tasks (phonemic/semantic word fluency, design fluency, gesture fluency and ideational fluency), requiring the generation of responses over a specified time period. Fluency performance was analysed in terms of the overall number of novel items produced, as well as the number of items produced in the first ‘initiation’ and the remaining ‘maintenance’ time periods. ALS patients' overall performance was not globally reduced across tasks. Patients were impaired only on meaningful gesture fluency, which requires the generation of gestures that communicate meaning ( e.g ., waving). On phonemic fluency, ALS patients showed a ‘drop off’ pattern of performance, where they had difficulty maintaining responding over time, but this pattern was not evident on the other fluency tasks. Apathy did not appear to be related to fluency performance. The selective meaningful gesture fluency deficit, in the context of preserved meaningless gesture fluency, highlights that the retrieval of action knowledge may be weakened in early ALS.


  • Open Access

    Phonemic Fluency in pathologically confirmed Alzheimer’s disease (AD) versus AD with Lewy Bodies

    by Jordan Johnson, Kayri K Fernandez, Megan S Barker, Michelle Hernandez, Elizabeth Soto, Yian Gu, Yaakov Stern, Stephanie Cosentino

    Background: Although Alzheimer’s Disease (AD) and Lewy Body Disease (LBD) have distinct underlying pathologies, the clinical differentiation of these disorders remains challenging, particularly AD versus mixed AD/LBD. Previous studies have shown that patients with mixed AD/DLB can have lower total output phonemic fluency than patients with AD. Examining the qualitative features of fluency performance may offer an even more sensitive approach to detecting group differences. One potentially useful measure is the ability to sustain generation of words over time; that is, whether a participant continues producing words across the full 60 seconds, or whether their responses “drop off”. A “drop off” in verbal generation on fluency tasks has previously been reported in Mild Cognitive Impairment due to AD. We assessed whether this qualitative phonemic fluency score would differ between autopsy confirmed AD versus mixed AD/DLB or DLB.Method: Participants with postmortem pathological diagnoses of AD (n = 15) and DLB (mixed or pure DLB; n = 8) were included in the present study. Participants completed phonemic fluency task at their baseline visit as part of a neuropsychological battery of tests. Participants were asked to generate as many words as possible that start with a given letter in one minute across three trials (i.e., C, F, L). The drop off in phonemic fluency over time was calculated by dividing the number of words produced in the second half of the test (i.e. second 30‐second interval) by the total number of words generated across 60 seconds. Group differences were analyzed using a one‐way analysis of variance (ANOVA).Result: Whereas total CFL score did not differ in this sample (p = .21), patients with DLB produced a significantly higher proportion of words in the second half of the CFL test (M = 0.40; SD = 0.14), compared to patients with pure AD (M = 0.27, SD = 0.10), p = 0.016.Conclusion: Novel scoring of the CFL test may help to differentiate cases with pure AD and cases with DLB pathology. In the current study, pure AD patients had more difficulty in sustaining word generation over 60 seconds. Future research should continue to look at different ways to score and analyze neuropsychological assessments to improve early differential diagnosis.